Official registry condition

Polycystic Ovary Syndrome peptide trials

4 selected ClinicalTrials.gov records carrying the official condition label Polycystic Ovary Syndrome. The label is copied from each retained registry version and does not imply that PeptideScanner has verified a diagnosis, treatment relationship, or study result.

Registry records

4 selected records.

Connected peptides

3 profiles.

Registry update years

2005–2025 in selected records.

Indication intelligence

Selected evidence landscape

Connected profiles3

Exact peptide identities attached to retained registry observations carrying this condition label.

Trial phases3

Phase labels copied from the retained ClinicalTrials.gov versions.

Registry statuses1

Overall statuses at each retained observation, not necessarily current today.

Across the connected peptide profiles, PeptideScanner also carries 76 selected PubMed records and 40 selected Drugs@FDA applications. Those records are profile context only; PeptideScanner does not claim they concern Polycystic Ovary Syndrome unless their own cited source says so.

Collection change ledger

Recently changed records on this condition hub

All recent changes →

These events come only from the exact registry records shown on this page. The condition label does not establish a diagnosis, treatment relationship, or scientific agreement.

Record added

ClinicalTrials.gov record NCT00757185

PeptideScanner retained ClinicalTrials.gov record NCT00757185 at 2026-11-15T22:03:26.540Z. Its registry update date was 2016-07-04, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
July 4, 2016
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT01402336

PeptideScanner retained ClinicalTrials.gov record NCT01402336 at 2026-11-15T22:02:39.332Z. Its registry update date was 2017-10-10, and PeptideScanner's reviewed identity mapping was cetrorelix.

PeptideScanner change date
November 15, 2026
Cited source date
October 10, 2017
Evidence lane
Clinical trials
Record added

ClinicalTrials.gov record NCT05751252

PeptideScanner retained ClinicalTrials.gov record NCT05751252 at 2026-11-15T22:03:26.540Z. Its registry update date was 2025-04-27, and PeptideScanner's reviewed identity mapping was ganirelix.

PeptideScanner change date
November 15, 2026
Cited source date
April 27, 2025
Evidence lane
Clinical trials

Attributed registry records

Selected records

All trial facets →